Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-12

Clinical Trial Update: Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal [NA]

View source ↗

Summary

A completed clinical trial evaluated dexmedetomidine as an adjunctive therapy for acute alcohol withdrawal; results were posted in May 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Precedex) (dexmedetomidine)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Acute Alcohol Withdrawal | NA | Status: COMPLETED | Results posted: 2016-05-12